Steven A. Tananbaum insider trades: Keenova Therapeutics stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Steven reports to the SEC
and 4 more companies
Open-market buys and sales
211 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 14, 2026 | NONE | ↑ Buy | 137,000 | $90.00 | $12.3M | Indirect | Oct 16, 2026 (2d) |
| Oct 9, 2026 | QVCG | ↑ Buy | 1,352,000 | $12.35 | $16.7M | Indirect | Oct 14, 2026 (5d) |
| Oct 2, 2026 | QVCG | ↑ Buy | 250,000 | $13.85 | $3.5M | Indirect | Oct 6, 2026 (4d) |
| Oct 1, 2026 | QVCG | ↑ Buy | 5,779 | $13.62 | $79K | Indirect | Oct 2, 2026 (1d) |
| Sep 24, 2026 | NONE | ↑ Buy | 463,000 | $91.00 | $42.1M | Indirect | Oct 6, 2026 (12d) |
| Sep 24, 2026 | QVCG | ↑ Buy | 80,000 | $14.35 | $1.1M | Indirect | Sep 28, 2026 (4d) |
| Sep 3, 2026 | QVCG | ↑ Buy | 720,000 | $16.45 | $11.8M | Indirect | Sep 8, 2026 (5d) |
| Aug 28, 2026 | QVCG | ↑ Buy | 23,609 | $15.80 | $373K | Indirect | Aug 31, 2026 (3d) |
| Aug 26, 2026 | QVCG | ↑ Buy | 2,451 | $15.24 | $37K | Indirect | Aug 27, 2026 (1d) |
| Aug 24, 2026 | QVCG | ↑ Buy | 2,890 | $15.23 | $44K | Indirect | Aug 25, 2026 (1d) |
| Aug 20, 2026 | QVCG | ↑ Buy | 14,280 | $15.21 | $217K | Indirect | Aug 21, 2026 (1d) |
| Aug 18, 2026 | QVCG | ↑ Buy | 44,942 | $15.18 | $682K | Indirect | Aug 19, 2026 (1d) |
| Aug 14, 2026 | QVCG | ↑ Buy | 45,338 | $15.19 | $689K | Indirect | Aug 17, 2026 (3d) |
| Aug 11, 2026 | QVCG | ↑ Buy | 650,808 | $15.35 | $10.0M | Indirect | Aug 11, 2026 (0d) |
| Jun 9, 2026 | NONE | ↑ Buy | 465,230 | $10.21 | $4.8M | Indirect | Jun 11, 2026 (2d) |
| May 26, 2026 | NONE | ↑ Buy | 1,254,921 | $10.16 | $12.8M | Indirect | May 28, 2026 (2d) |
| Apr 24, 2026 | NONE | ↑ Buy | 1,956,947 | $10.22 | $20.0M | Indirect | Apr 28, 2026 (4d) |
| Apr 21, 2026 | NONE | ↑ Buy | 3,662,109 | $10.24 | $37.5M | Indirect | Apr 23, 2026 (2d) |
| Feb 13, 2026 | NONE | ↑ Buy | 971,817 | $10.29 | $10.0M | Indirect | Feb 18, 2026 (5d) |
| Nov 28, 2025 | NONE | ↑ Buy | 1,949,318 | $10.26 | $20.0M | Indirect | Dec 2, 2025 (4d) |
| Sep 12, 2025 | NONE | ↑ Buy | 2,942,913 | $10.16 | $29.9M | Indirect | Sep 16, 2025 (4d) |
| Aug 28, 2025 | NONE | ↑ Buy | 2,967,359 | $10.11 | $30.0M | Indirect | Sep 2, 2025 (5d) |
| Aug 11, 2025 | NONE | ↑ Buy | 1,492,537 | $10.05 | $15.0M | Indirect | Aug 13, 2025 (2d) |
| Aug 7, 2025 | NONE | ↑ Buy | 1,494,024 | $10.04 | $15.0M | Indirect | Aug 11, 2025 (4d) |
| Aug 6, 2025 | NONE | ↑ Buy | 36,700 | $88.21 | $3.2M | Indirect | Aug 6, 2025 (0d) |
| Aug 1, 2025 | NONE | ↑ Buy | 50,000 | $86.50 | $4.3M | Indirect | Aug 4, 2025 (3d) |
| Jul 16, 2025 | NONE | ↑ Buy | 6,000,000 | $10.00 | $60.0M | Indirect | Jul 18, 2025 (2d) |
| Jul 8, 2024 | MNKTQ | ↑ Buy | 13,300 | $54.50 | $725K | Indirect | Jul 10, 2024 (2d) |
| Jun 14, 2024 | MNKTQ | ↑ Buy | 275,000 | $52.75 | $14.5M | Indirect | Jun 18, 2024 (4d) |
| May 24, 2024 | MNKTQ | ↑ Buy | 165,000 | $50.00 | $8.3M | Indirect | May 29, 2024 (5d) |
| May 9, 2024 | MNKTQ | ↑ Buy | 475,000 | $55.37 | $26.3M | Indirect | May 13, 2024 (4d) |
| Mar 8, 2024 | MNKTQ | ↑ Buy | 83,000 | $43.63 | $3.6M | Indirect | Mar 12, 2024 (4d) |
| Feb 15, 2024 | MNKTQ | ↑ Buy | 225,000 | $38.25 | $8.6M | Indirect | Feb 20, 2024 (5d) |
| Feb 2, 2024 | MNKTQ | ↑ Buy | 20,000 | $37.55 | $751K | Indirect | Feb 6, 2024 (4d) |
| Dec 5, 2023 | MNKTQ | ↑ Buy | 75,000 | $37.50 | $2.8M | Indirect | Dec 13, 2023 (8d) |
| Apr 6, 2022 | CRC | ↓ Sell | 229,302 | $44.34 | $10.2M | Indirect | Apr 7, 2022 (1d) |
| Mar 30, 2022 | CRC | ↓ Sell | 376,691 | $48.60 | $18.3M | Indirect | Mar 31, 2022 (1d) |
| Mar 28, 2022 | CRC | ↓ Sell | 609,209 | $49.35 | $30.1M | Indirect | Mar 29, 2022 (1d) |
| Mar 21, 2022 | CRC | ↓ Sell | 5,055 | $43.65 | $221K | Indirect | Mar 22, 2022 (1d) |
| Mar 7, 2022 | CRC | ↓ Sell | 65,494 | $43.71 | $2.9M | Indirect | Mar 10, 2022 (3d) |
| Jan 20, 2022 | CRC | ↓ Sell | 10,200 | $43.92 | $448K | Indirect | Jan 24, 2022 (4d) |
| Jan 14, 2022 | CRC | ↓ Sell | 28,313 | $45.10 | $1.3M | Indirect | Jan 18, 2022 (4d) |
| Jan 12, 2022 | CRC | ↓ Sell | 323,180 | $44.05 | $14.2M | Indirect | Jan 13, 2022 (1d) |
| Jan 6, 2022 | CRC | ↓ Sell | 50,615 | $44.44 | $2.2M | Indirect | Jan 7, 2022 (1d) |
| Jan 4, 2022 | CRC | ↓ Sell | 330,354 | $44.02 | $14.5M | Indirect | Jan 5, 2022 (1d) |
| Dec 30, 2021 | CRC | ↓ Sell | 3,746 | $43.57 | $163K | Indirect | Jan 3, 2022 (4d) |
| Dec 28, 2021 | CRC | ↓ Sell | 15,918 | $43.56 | $693K | Indirect | Dec 29, 2021 (1d) |
| Dec 20, 2021 | CRC | ↑ Buy | 6,900 | $38.70 | $267K | Indirect | Dec 22, 2021 (2d) |
| Dec 13, 2021 | CRC | ↓ Sell | 10,659 | $44.11 | $470K | Indirect | Dec 15, 2021 (2d) |
| Dec 10, 2021 | CRC | ↓ Sell | 85,408 | $44.88 | $3.8M | Indirect | Dec 13, 2021 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Steven A. Tananbaum's insider trades
Steven A. Tananbaum is a 10% owner of Keenova Therapeutics. Since Oct 24, 2008, Steven has reported 84 open-market purchases worth $494.5M and 127 sales worth $652.9M on SEC Form 4. In the last 12 months: 20 buys ($204.7M).
Their filings also include other transactions (25 filings), option exercises (1 filing), grants and awards (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.